Trial intelligence / Profile preview

ED90 of sufentanil bolus for painful nursing care in intubated ICU patients

2009-014741-89Phase 4Active

Sponsor
Centre hospitalier universitaire de Toulouse
Start
Aug 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of sufentanil in pain, sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: ED90 of sufentanil bolus. Started Aug 2009; status: active.

02

Drugs

sufentanil
03

Conditions

pain

Beyond the preview

Go deeper on 2009-014741-89.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-014741-89.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call